1. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine
    Simeng Zhang et al, 2022, EPMA Journal CrossRef
  2. Hexokinases II ‐mediated glycolysis governs susceptibility to crizotinib in ALK ‐positive non‐small cell lung cancer
    Caiyu Lin et al, 2021, Thoracic Cancer CrossRef
  3. A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
    Jiaqi Su et al, 2022, Frontiers in Oncology CrossRef
  4. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent
    Xilin Zhang et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef